☰

Kai L. Yap, Ph.D. - Publications

Affiliations: 
2012 Johns Hopkins University, Baltimore, MD 
Area:
Oncology, Pathology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Zewde M, Kiyotani K, Park JH, Fang H, Yap KL, Yew PY, Alachkar H, Kato T, Mai TH, Ikeda Y, Matsuda T, Liu X, Ren L, Deng B, Harada M, et al. The era of immunogenomics/immunopharmacogenomics. Journal of Human Genetics. PMID 29785006 DOI: 10.1038/S10038-018-0468-1  0.349
2016 Choudhury NJ, Kiyotani K, Yap KL, Campanile A, Antic T, Yew PY, Steinberg G, Park JH, Nakamura Y, O'Donnell PH. Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer. European Urology Focus. 2: 445-452. PMID 28723478 DOI: 10.1016/J.Euf.2015.09.007  0.388
2016 Yap KL, Furtado LV, Kiyotani K, Curran E, Stock W, McNeer JL, Kadri S, Segal JP, Nakamura Y, Le Beau MM, Gurbuxani S, Raca G. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & Lymphoma. 1-9. PMID 27855558 DOI: 10.1080/10428194.2016.1219902  0.304
2016 Ikeda Y, Kiyotani K, Yew PY, Kato T, Tamura K, Yap KL, Mester JL, Nielsen SH, Raymon GH, Eng C, Nakamura Y. Abstract 3480: Germline PARP4 mutations in patients with primary thyroid and breast cancers Cancer Research. 76: 3480-3480. DOI: 10.1158/1538-7445.Am2016-3480  0.358
2015 Ikeda Y, Kiyotani K, Yew PY, Kato T, Tamura K, Yap KL, Nielsen S, Mester J, Eng C, Nakamura Y, Grogan RH. Germline PARP4 mutations in patients with primary thyroid and breast cancers. Endocrine-Related Cancer. PMID 26699384 DOI: 10.1530/Erc-15-0359  0.393
2015 Choudhury N, Yap KL, Kiyotani K, Yew PY, Campanile A, Antic T, Steinberg G, Park J, O'Donnell PH, Nakamura Y. Abstract 4899: Tumor T-cell receptor (TCR) diversity elucidates the immune response to genetic alterations of muscle-invasive bladder cancer Cancer Research. 75: 4899-4899. DOI: 10.1158/1538-7445.Am2015-4899  0.338
2014 Yap KL, Kiyotani K, Tamura K, Antic T, Jang M, Montoya M, Campanile A, Yew PY, Ganshert C, Fujioka T, Steinberg GD, O'Donnell PH, Nakamura Y. Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6605-17. PMID 25316812 DOI: 10.1158/1078-0432.Ccr-14-0257  0.333
2014 Gao M, Wu RC, Herlinger AL, Yap K, Kim JW, Wang TL, Shih IeM. Identification of the NAC1-regulated genes in ovarian cancer. The American Journal of Pathology. 184: 133-40. PMID 24200849 DOI: 10.1016/J.Ajpath.2013.09.024  0.655
2014 Yap KL, Kiyotani K, Tamura K, Jang M, Montoya M, Ganshert C, Fujioka T, Steinberg G, O'Donnell P, Nakamura Y. Abstract 3430: Recurrent somatic mutations of nitric oxide synthaseNOS3, netrin receptorUNC5Cand DNA repair genes in muscle-invasive bladder carcinoma Cancer Research. 74: 3430-3430. DOI: 10.1158/1538-7445.Am2014-3430  0.39
2013 Yap KL, Sysa-Shah P, Bolon B, Wu RC, Gao M, Herlinger AL, Wang F, Faiola F, Huso D, Gabrielson K, Wang TL, Wang J, Shih IeM. Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis. Plos One. 8: e69099. PMID 23922682 DOI: 10.1371/Journal.Pone.0069099  0.605
2012 Yap KL, Fraley SI, Thiaville MM, Jinawath N, Nakayama K, Wang J, Wang TL, Wirtz D, Shih IeM. NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells. Cancer Research. 72: 4085-96. PMID 22761335 DOI: 10.1158/0008-5472.Can-12-0302  0.6
2012 Zhang Y, Cheng Y, Ren X, Hori T, Huber-Keener KJ, Zhang L, Yap KL, Liu D, Shantz L, Qin ZH, Zhang S, Wang J, Wang HG, Shih IeM, Yang JM. Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis. Cancer Research. 72: 4262-75. PMID 22665267 DOI: 10.1158/0008-5472.Can-12-0139  0.431
2012 Zhang Y, Cheng Y, Ren X, Zhang L, Yap KL, Wu H, Patel R, Liu D, Qin ZH, Shih IM, Yang JM. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene. 31: 1055-64. PMID 21743489 DOI: 10.1038/Onc.2011.290  0.437
2012 Yap KL, Fraley SI, Shah PS, Wang F, Thiaville MM, Jinawath N, Nakayama K, Wang J, Brayton C, Bolon B, Gabrielson K, Wirtz D, Wang T, Shih I. Abstract LB-115: NAC1 is an actin binding protein essential for the cytokinesis of cancer cells and plays a role in the patterning of murine vertebral axis Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-115  0.611
2011 Yap KL, Fraley SI, Thiaville MM, Jinawath N, Nakayama K, Wang J, Wirtz D, Wang T, Shih l. Abstract B18: Identification and characterization of NAC1 as a profilin1/actin-binding protein that is essential for effective cytokinesis in cancer cells Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-B18  0.611
2011 Zhang Y, Cheng Y, Ren X, Yap KL, Shih I, Yang J. Abstract 2877: NAC1 modulates sensitivity of ovarian cancer cells to cisplatin via altering HMGB1 expression and autophagic response Cancer Research. 71: 2877-2877. DOI: 10.1158/1538-7445.Am2011-2877  0.488
2010 Jinawath N, Vasoontara C, Jinawath A, Fang X, Zhao K, Yap KL, Guo T, Lee CS, Wang W, Balgley BM, Davidson B, Wang TL, Shih IeM. Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma. Plos One. 5: e11198. PMID 20585448 DOI: 10.1371/Journal.Pone.0011198  0.592
2010 Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM. Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas. Journal of Oncology. 2010: 285191. PMID 20508725 DOI: 10.1155/2010/285191  0.604
2009 Jinawath N, Vasoontara C, Yap KL, Thiaville MM, Nakayama K, Wang TL, Shih IM. NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway. Oncogene. 28: 1941-8. PMID 19305429 DOI: 10.1038/Onc.2009.37  0.617
2007 Krishnan V, Dirick L, Lim HH, Lim TS, Si-Hoe SL, Cheng CS, Yap KL, Ting A, Schwob E, Surana U. A novel cell cycle inhibitor stalls replication forks and activates S phase checkpoint. Cell Cycle (Georgetown, Tex.). 6: 1621-30. PMID 17603303 DOI: 10.4161/Cc.6.13.4373  0.304
Show low-probability matches.